The Long Run with Luke Timmerman
Ein Podcast von Timmerman Report
173 Folgen
-
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
Vom: 6.3.2024 -
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
Vom: 9.2.2024 -
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
Vom: 22.1.2024 -
Ep152: Jens Eckstein on Investing in Healthy Aging
Vom: 10.1.2024 -
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
Vom: 26.12.2023 -
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
Vom: 13.12.2023 -
Ep149: Nancy Stagliano on Precision Neuroscience
Vom: 29.11.2023 -
Ep148: Diana Brainard on the Fight Against Infectious Disease
Vom: 13.11.2023 -
Ep147: Reid Huber on Investing in the Future of Medicine
Vom: 1.11.2023 -
Ep146: Jeff Huber on Life in Tech and Biotech
Vom: 17.10.2023 -
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
Vom: 3.10.2023 -
Ep144: Turning the Tables, Rob Perez Interviews Me
Vom: 19.9.2023 -
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
Vom: 6.9.2023 -
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
Vom: 24.8.2023 -
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
Vom: 8.8.2023 -
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
Vom: 24.7.2023 -
Ep139: Kevin Conroy on Early Detection of Cancer
Vom: 10.7.2023 -
Ep138: Jodie Morrison on Becoming a Biotech CEO
Vom: 27.6.2023 -
Ep137: Aaron Ring on Immunotherapy for Cancer & More
Vom: 14.6.2023 -
Ep136: Deborah Palestrant on Building Biotech Startups
Vom: 30.5.2023
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
